Login
$VCYT
$24.09 -$0.24 (0.99%) Live

Insider Transactions

What VERACYTE, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 13 50
Total trades 23 111

Shares traded

3 months 12 months
Acquired 25,000 951,908
Disposed 88,476 641,652
Net activity −63,476 +310,256

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Wygant Jonathan VP, Chief Accounting Officer Oct 28 Withheld — tax / exercise cost · F −1,306 $50.31 −$65.7K 41,920
Holstein Jens Director Oct 27 Open-market sale · S −7,500 $50.00 −$375K 27,471
Holstein Jens Director Oct 27 Exercise / conversion · M +7,500 $35.30 +$265K 34,971
Eastham Karin Director Oct 27 Open-market sale · S −14,850 $50.00 −$743K 10,247
Eastham Karin Director Oct 27 Exercise / conversion · M +10,000 $27.01 +$270K 25,097
Bhanji Muna Director Oct 19 Open-market sale · S −1,864 $43.70 −$81.5K 40,854
Holstein Jens Director Sep 24 Open-market sale · S −7,500 $47.00 −$353K 27,471
Holstein Jens Director Sep 24 Exercise / conversion · M +7,500 $35.30 +$265K 34,971
Leite John Global Chief Commercial Off Sep 21 Open-market sale · S −4,015 $40.00 −$161K 124,329
Holstein Jens Director Sep 14 Open-market sale · S −5,000 $40.95 −$205K 27,471
McGuire Annie EVP, General Counsel Sep 04 Open-market sale · S −1,100 $43.67 −$48K 131,160
McGuire Annie EVP, General Counsel Sep 04 Open-market sale · S −2,154 $42.79 −$92.2K 132,260
Chambers Rebecca Chief Financial Officer Sep 04 Open-market sale · S −1,175 $43.71 −$51.4K 166,025
Chambers Rebecca Chief Financial Officer Sep 04 Open-market sale · S −2,477 $42.81 −$106K 167,200
Febbo Phillip G. Chief Scientific & Med Officer Sep 04 Open-market sale · S −2,705 $43.66 −$118K 133,048
Febbo Phillip G. Chief Scientific & Med Officer Sep 04 Open-market sale · S −10,405 $42.89 −$446K 135,753
Wygant Jonathan VP, Chief Accounting Officer Sep 02 Withheld — tax / exercise cost · F −1,361 $44.88 −$61.1K 43,226
McGuire Annie EVP, General Counsel Sep 02 Withheld — tax / exercise cost · F −3,215 $44.88 −$144K 134,414
Stapley Marc Chief Executive Officer Sep 02 Withheld — tax / exercise cost · F −8,782 $44.88 −$394K 432,073
Chambers Rebecca Chief Financial Officer Sep 02 Withheld — tax / exercise cost · F −3,603 $44.88 −$162K 169,677

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support